Back to today’s briefing

Story perspectives

Breakthrough Reveals IL-12's Role in Alzheimer's Progression

3/17/2025

50 10

Summary

Story summary

Researchers at Charité – Universitätsmedizin Berlin and the Max Delbrück Center have uncovered a crucial link between interleukin-12 (IL-12) and the progression of Alzheimer’s disease. Their findings show that IL-12 harms vital brain cells, accelerating cognitive decline. This breakthrough could inspire innovative combination therapies aimed at combating inflammation in Alzheimer’s, utilizing existing IL-12 blockers.

1 of 1

Story summary

Researchers at Charité – Universitätsmedizin Berlin and the Max Delbrück Center have uncovered a crucial link between interleukin-12 (IL-12) and the progression of Alzheimer’s disease. Their findings show that IL-12 harms vital brain cells, accelerating cognitive decline. This breakthrough could inspire innovative combination therapies aimed at combating inflammation in Alzheimer’s, utilizing existing IL-12 blockers.